JACOBS LEVY EQUITY MANAGEMENT, INC Travere Therapeutics, Inc. Transaction History

JACOBS LEVY EQUITY MANAGEMENT, INC portfolio value:

$17.94M
portfolio value

JACOBS LEVY EQUITY MANAGEMENT, INC quarter portfolio value change:

+1.69%
quarter

Travere Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +30.51% 170.21K shares 4.42M $24.64 728.11K
Q2 2022 share Decrease -39.72% -367.54K shares -10.33M $24.23 557.90K
Q1 2022 share Decrease -1.45% -13.64K shares -5.3M $25.77 925.44K
Q4 2021 share Decrease -9.04% -93.30K shares 4.11M $30.31 939.09K
Q3 2021 share Increase +30.53% 241.46K shares 13.49M $24.25 1.03M
Q2 2021 share Increase +23.36% 149.75K shares -4.47M $14.59 790.93K
Q1 2021 share Decrease -0.76% -4.87K shares -1.59M $24.97 641.17K
Q4 2020 share Increase 0.00% 646.05K shares 17.60M $27.26 646.05K